Antiretroviral News and Research

RSS

Americans give Russia $34.2 million to help treat and care for people living with HIV/AIDS and tuberculosis

HHS Secretary Tommy G. Thompson announced today that the Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Russia $34.2 million over two years to help treat and care for people living with HIV/AIDS and tuberculosis.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet.

2 Jul 2004

Women delay AIDS with vitamins B, C and E

Daily intake of multivitamins appears to delay the progress of the AIDS virus according to the results of a study of HIV infected women in Tanzania by Harvard researchers.

30 Jun 2004

Bush outlines government actions on HIV/AIDS

President Bush visited Philadelphia, Pennsylvania last week, to discuss the need for providing treatment to Americans living with HIV/AIDS, and to highlight the work of faith-based and community organizations as they seek to treat and care for Americans living with HIV/AIDS.

26 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries

25 Jun 2004

Treatment of cytomegalovirus remains a priority in order to improve the prognosis for people with HIV-1 infection

Treatment of cytomegalovirus infection remains a priority in order to improve the prognosis for people with HIV-1 infection, including people already receiving antiretroviral therapy

24 Jun 2004

2000 Ukrainian patients to receive treatment for HIV/AIDS

A contract, worth 3,6 million dollars, was signed between the two parties, for the delivery of multi-source antiretrovirals in 2004.

22 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Harmless virus known as GBV-C slows the progression of HIV

Iowa City Veterans Affairs (VA) Medical Center and University of Iowa (UI) researchers have unlocked part of the mystery of how a harmless virus known as GBV-C slows the progression of HIV and prolongs survival for many patients.

17 Jun 2004

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Today Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment, accounting for more than half of all people on antiretrovirals in developing countries, according to the Pan American Health Organization (PAHO).

15 Jun 2004

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

Researchers at the Institute of Human Virology have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods.

15 Jun 2004

Gay men casual about HIV

One in three HIV positive gay men don't know they are infected with the virus, suggests a large community study in Sexually Transmitted Infections.

1 Jun 2004

New UK HIV infection data

In the first three months of 2004, 1389 new diagnoses of HIV infection in the UK were reported. This brought the cumulative total to 62,709 since surveillance began in 1982.

1 Jun 2004

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

24 May 2004

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

The World Health Assembly, the supreme decision-making body of the World Health Organization, has raised global public health to a new level, by resolving to take more action to prevent death and illness resulting from heart disease, diabetes, cancers, road safety, and lack of access to health services as well as from diseases spread by viruses, bacteria and other dangerous microbes.

22 May 2004

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles. This approach is known formally as “short-cycle structured intermittent antiretroviral therapy” (SIT) or colloquially as the “7-7” approach.

20 May 2004

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans to ensure that the thousands of HIV-infected people currently not receiving care through existing programs gain access to the services they need, says a new report from the Institute of Medicine of the National Academies.

16 May 2004

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

The idea is to use a modified form of HIV to deliver an "antisense" gene to the immune cells that HIV infects. This is integrated into the cells' genome, and stays there until a cell is infected. Then it is switched on, and produces RNA complementary to the "sense" RNA encoding a viral protein. In theory, the RNAs should bind together, blocking viral replication.

14 May 2004

WHO admits target on AIDS drugs may be unrealistic

In its Annual World Health Report 2004, the WHO said that more donor funds than ever before, at least $20.5bn (£11.5bn; 17.3bn), are available for AIDS relief in the world's poorest countries, but a huge concerted effort will be needed to get antiretroviral drugs to millions of people who need them before it is too late.

14 May 2004

Antiretroviral News and Research

Americans give Russia $34.2 million to help treat and care for people living with HIV/AIDS and tuberculosis

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Women delay AIDS with vitamins B, C and E

Bush outlines government actions on HIV/AIDS

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Treatment of cytomegalovirus remains a priority in order to improve the prognosis for people with HIV-1 infection

2000 Ukrainian patients to receive treatment for HIV/AIDS

WHO removes two antiretroviral products from the WHO List of prequalified products

Harmless virus known as GBV-C slows the progression of HIV

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

Gay men casual about HIV

New UK HIV infection data

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

WHO to tackle heart disease, diabetes, cancers, road safety as well as diseases

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

WHO admits target on AIDS drugs may be unrealistic

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News